Search Options Stock News and Analysis from Schaeffer's

https://www.schaeffersresearch.com/content/news/2019/10/24/analyst-biotech-stock-to-drop-now

10/24/2019 10:19 AM

Shares of Acorda Therapeutics Inc (NASDAQ:ACOR) are plunging this morning, already down 13.9% to trade at $2.33. Acorda issued a double-whammy last night, sharing its corporate restructuring plan -- ...

ACOR Stock Pops on FDA Nod

https://www.schaeffersresearch.com/content/news/2018/12/24/acor-stock-pops-on-fda-nod

12/24/2018 11:32 AM

Acorda Therapeutics (NASDAQ:ACOR) shares are up 5% at $13.59 today, lifted by Friday's late-breaking news that the Food and Drug Administration (FDA) approved its new Parkinson's drug. The inhalable t...

D.C. Headlines Drive Dow Futures Lower

https://www.schaeffersresearch.com/content/ezines/2018/12/24/dc-headlines-drive-dow-futures-lower

12/24/2018 9:11 AM

It's an abbreviated session on Wall Street today, with the stock market closing at 1 p.m. ET for the Christmas holiday, and shuttered all day tomorrow. Traders are less than cheerful, with Dow Jone...

Goldman: Sell This Biotech Stock Now

https://www.schaeffersresearch.com/content/news/2018/12/11/goldman-sell-this-biotech-stock-now

12/11/2018 11:33 AM

The shares of Acorda Therapeutics Inc (NASDAQ:ACOR) are spiraling today, after Goldman Sachs downgraded the drug stock to "sell" from "neutral," and nearly halved its price target to $10 from $19 -- ...

Dow Erases Weekly Gain as Bond Yields Continue to Climb

https://www.schaeffersresearch.com/content/ezines/2018/10/05/dow-erases-weekly-gain-as-bond-yields-continue-to-climb

10/5/2018 12:06 PM

U.S. stocks are suffering notable losses at midday, as bond yields continue to rise on the back of this morning's jobs data. The S&P 500 Index (SPX) is heading toward its first close below 2,900 ...

PEOPLE ALSO SEARCH FOR